Scott Huennekens

Scott is a successful Medtech CEO, Chairman, board member, entrepreneur, and investor, having been involved in one of those roles in 20+ startup, growth, and public companies with market valuations that have totaled over $20b and more importantly over 20 million patients that have benefited from the therapies and diagnostics of these companies. Current professional affiliations include Executive Chairman Acutus Medical (NASDAQ: AFIB) IPO August 2020, Chairman Envista (NYSE: NVST) IPO September 2019, Board Member Nuvasive (NASDAQ: NUVA), Board Member ViewRay (NASDAQ: VRAY), Executive Chairman Digma Medical, Executive Chairman Wondr Medical, Board Member Kardion, Board Member & past Chairman Medical Device Manufacturer’s Association (MDMA), and advisor to Peloton Equity, 8VC, and Accelmed Equity.

He graduated Magna Cum Laude with a BS in Bus Admin from the Univ. of Southern California and earned his MBA from Harvard Business School. Past affiliations include 9 other public and or VC-funded medtech and biotech company boards of which 6 have had exits over $300 million. Scott has also been awarded E&Y’s entrepreneur of the year award in 2010 & was recognized by Goldman Sachs in 2016, 2017, & 2018 as one of the 100 most intriguing entrepreneurs at its annual Builders & Innovators conference.